71.95EUR+2.79%Mkt Cap: 11.02B $P/E: 19.141d ago
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Avg
P/B
Pricier
Div Yield
Avg
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap11.02B $
Enterprise Value11.16B $
Revenue (TTM)2.12B $
Gross Profit1.32B $
Net Income (TTM)543.80M $
Revenue/Share15.08 USD
Last Price71.95 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.1K
CountryFI
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFI0009014377
Valuation
P/E (Trailing)19.14
P/E (Forward)15.60
PEG5.73
EV/EBITDA14.24
EV/Revenue5.26
P/S5.19
P/B9.03
EPS (TTM)3.76
EPS (Forward)4.61
52W Range
56.5082% of range75.30
52W High75.30 EUR
52W Low56.50 EUR
Profitability
Gross Margin64.20%
Oper. Margin27.46%
EBITDA Margin36.91%
Profit Margin26.48%
ROE38.95%
ROA24.89%
Growth
Revenue Growth17.80%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF344.35M $
CapEx (TTM)106.09M $
FCF Margin16.81%
FCF Yield3.24%
Net Debt142.39M $
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity0.24
Current Ratio1.77
Quick Ratio1.13
Book Value/Sh7.968 EUR
Cash/Share1.415 EUR
Dividends
Fwd Div Rate1.800 EUR
Trail. Div Rate1.800 EUR
Div. Yield2.53%
5Y Avg Yield3.29%
Payout Ratio45.74%
Ex-Div DateOct 19, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)74.33 EUR
Upside (mean)+3.3%
Target Range55.00 EUR – 81.00 EUR
€55.00+3.3% to mean€81.00
# Analysts6
Ownership
Shares Out.109.34M
Float123.11M
Insiders2.64%
Institutions44.98%
Technical
SMA 5069.65 (+3.3%)
SMA 20067.11 (+7.2%)
Beta0.28
S&P 52W Chg20.05%
Avg Vol (30d)211.29K
Avg Vol (10d)158.56K
Technical Indicators
RSI (14)61.2
MACD0.1246
MACD Signal-0.2443
MACD Hist.+0.3688
BB Upper71.64 EUR
BB Middle68.99 EUR
BB Lower66.34 EUR
BB Width7.69%
ATR (14)1.668 EUR
Vol Ratio (20d)0.86x